The study conducted on MDA-MB-231 and its derived breast cancer stem cells (BCSC) revealed that the anti-metastatic effect of curcumin was induced through the regulation of EMT-related markers, including β-catenin, vimentin, E-cadherin, N-cadherin, and fibronectin. Here, CDH1 is linked to breast carcinoma.